UNICREDIT BANK/CALL/VERTEX PHARMACEUTICALS/700/0.1/18.06.25

UNICREDIT BANK/CALL/VERTEX PHARMACEUTICALS/700/0.1/18.06.25 Share Price

DE000HD21V08

Real-time Boerse Frankfurt Warrants 11:31:02 20/05/2024 BST
0.44 ^EUR	-13.73%

Current month	+142.86%
1 month	+50.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart VERTEX PHARMACEUTICALS INCORPORATED

Chart UNICREDIT BANK/CALL/VERTEX PHARMACEUTICALS/700/0.1/18.06.25

Latest news about VERTEX PHARMACEUTICALS INCORPORATED

Jennifer Schneider Elected to Vertex Board of Directors	05-15	BU
Vertex Pharmaceuticals Incorporated Appoints Jennifer Schneider as Independent Director	05-15	CI
Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497	05-14	MT
Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone	05-10	MT

More news

Quotes 5-day view

Date	Price	Change
20/05/24	0.44	-13.73%
17/05/24	0.51	+2.00%
16/05/24	0.5	0.00%
15/05/24	0.5	+35.14%
14/05/24	0.37	-5.13%

Real-time Boerse Frankfurt Warrants

Last update May 20, 2024 at 11:31 am

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	VERTEX PHARMACEUTICALS INCORPORATED
Issuer	UniCredit
WKN	HD21V0
ISIN	DE000HD21V08
Date issued	23/01/2024
Strike	700 $
Maturity	18/06/2025 (395 Days)
Parity	10 : 1
Emission price	1.33 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	1.22 €
Lowest since issue	0.073 €
Spread	0.26 €
Spread %	37.14%

Company Profile

Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).

Sector

More about the company